Economics

This channel highlights factors that impact hospital and healthcare economics and revenue. This includes news on healthcare policies, reimbursement, marketing, business plans, mergers and acquisitions, supply chain, salaries, staffing, and the implementation of a cost-effective environment for patients and providers.

RSS icon
Thumbnail

Pfizer to buy cancer drug maker Medivation for $14 billion

Pharmaceutical giant Pfizer has announced a new merger agreement with cancer drug company Medivation in a $14 billion deal that would add the expensive prostate cancer drug Xtandi to its portfolio.

PlatformQ Health and Global Genes partner to form the Google of rare diseases

Global Genes and PlatformQ Health are patterning up to develop the Google of rare disease, RareUniversity.

Xenetic, Excivion to develop Zika vaccine

Since news broke that the Zika virus, which has been plaguing parts of South America and Puerto Rico, has spread to Florida, the urgency for prevention tactics have increased in the U.S.

Nashville Healthcare IT companies attracting venture capitalists

Nashville healthcare IT companies are booming this year and quickly becoming the most popular sector of healthcare in the city among venture capitalists, according to new research.

Spreemo names new leadership as it continues executive-level expansion

Healthcare analytics company Spreemo has continued its executive-level this week, only a week after naming a new president and COO.

Johnson & Johnson loses battle on rheumatoid arthritis drug patent

A federal judge told drug maker Johnson & Johnson it will not get to hold onto its patent for the rheumatoid arthritis drug Remicade. 

ProclaRx names Doug Martin COO

Biotechnology company ProclaRx named a new chief operation officer today as it switches up its executive team.

Sasmar Pharmaceuticals acquires Chicago-based Aquatrove

Sasmar Pharmaceuticals, a Belgium-based pharmaceutical manufacturer, has acquired Aquatrove Biosciences this week as it continues to expand its portfolio of biotechnology companies that will help improve its product pipeline.

Displaying 1849 - 1856 of 2290

Around the web

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Cardiovascular Business
Cardiology groups cheer new bill that would improve access to Medicare claims data

If passed, this bill would help clinician-led clinical registries explore Medicare data for research purposes. The Society of Thoracic Surgeons and American College of Cardiology both shared public support for the bipartisan legislation. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup